| Alecensa 150 mg hard capsules EU/1/16/1169/001 |
Alectinib hydrochloride |
Roche Registration GmbH |
— |
| Avastin 25 mg/ml concentrate for solution for infusion EU/1/04/300/001-002 |
Bevacizumab |
Roche Registration GmbH |
— |
| Avastin 25 mg/ml Concentrate for solution for infusion EU/1/04/300/1-2 |
Bevacizumab |
Roche Registration Limited |
— |
| CellCept 1 g/5 ml Powder for oral suspension EU/1/96/005/006 |
Mycophenolate mofetil |
Roche Registration GmbH |
— |
| CellCept 250 mg Capsule, hard EU/1/96/005/001 |
Mycophenolate mofetil |
Roche Registration GmbH |
— |
| CellCept 250 mg Capsule, hard EU/1/96/005/003 |
Mycophenolate mofetil |
Roche Registration GmbH |
— |
| CellCept 500 mg Film-coated tablet EU/1/96/005/002 |
Mycophenolate mofetil |
Roche Registration GmbH |
— |
| CellCept 500 mg Film-coated tablet EU/1/96/005/004 |
Mycophenolate mofetil |
Roche Registration GmbH |
— |
| CellCept 500 mg Powder for concentrate for solution for infusion EU/1/96/005/005 |
Mycophenolate mofetil |
Roche Registration GmbH |
— |
| Columvi 10 mg concentrate for solution for infusion EU/1/23/1742/002 |
Glofitamab |
Roche Registration GmbH |
— |
| Columvi 2.5 mg concentrate for solution for infusion EU/1/23/1742/001 |
Glofitamab |
Roche Registration GmbH |
— |
| Cotellic 20 mg film-coated tablets EU/1/15/1048/001 |
Cobimetinib hemifumarate |
Roche Registration GmbH |
— |
| Enspryng 120 mg solution for injection in pre-filled syringe EU/1/21/1559/001 |
Satralizumab |
Roche Registration GmbH |
— |
| Erivedge 150 mg hard capsules EU/1/13/848/001 |
Vismodegib |
Roche Registration GmbH |
— |
| Esbriet 267 mg hard capsules EU/1/11/667/001-003 |
Pirfenidone |
Roche Registration GmbH |
— |
| Evrysdi 0.75 mg/mL powder for oral solution EU/1/21/1531/001 |
Risdiplam |
Roche Registration GmbH |
— |
| Evrysdi 5 mg film-coated tablets EU/1/21/1531/002 |
Risdiplam |
Roche Registration GmbH |
— |
| Fuzeon EU/1/03/252/001 |
Enfuvirtide |
Roche Registration GmbH |
Not marketed |
| Gazyvaro 1,000 mg concentrate for solution for infusion EU/1/14/937/001 |
Obinutuzumab |
Roche Registration GmbH |
— |
| Hemlibra 150 mg/mL solution for injection EU/1/18/1271/002-004 |
Emicizumab |
Roche Registration GmbH |
— |
| Hemlibra 30 mg/mL solution for injection EU/1/18/1271/001 |
Emicizumab |
Roche Registration GmbH |
— |
| Herceptin 150 mg powder for concentrate for solution for infusion EU/1/00/145/001 |
Trastuzumab |
Roche Registration GmbH |
— |
| Herceptin 600 mg solution for injection in vial EU/1/00/145/002 |
Trastuzumab |
Roche Registration GmbH |
— |
| Itovebi 3 mg film-coated tablets EU/1/25/1942/001 |
Inavolisib |
Roche Registration GmbH |
— |
| Itovebi 9 mg film-coated tablets EU/1/25/1942/002 |
Inavolisib |
Roche Registration GmbH |
— |
| Kadcyla 100 mg powder for concentrate for solution for infusion EU/1/13/885/001 |
Trastuzumab emtansine |
Roche Registration GmbH |
— |
| Kadcyla 160 mg powder for concentrate for solution for infusion EU/1/13/885/002 |
Trastuzumab emtansine |
Roche Registration GmbH |
— |
| Lunsumio 1 mg concentrate for solution for infusion EU/1/22/1649/001 |
Mosunetuzumab |
Roche Registration GmbH |
— |
| Lunsumio 30 mg concentrate for solution for infusion EU/1/22/1649/002 |
Mosunetuzumab |
Roche Registration GmbH |
— |
| Lunsumio 45 mg solution for injection EU/1/22/1649/004 |
Mosunetuzumab |
Roche Registration GmbH |
— |
| Lunsumio 5 mg solution for injection EU/1/22/1649/003 |
Mosunetuzumab |
Roche Registration GmbH |
— |
| MabThera 100 mg concentrate for solution for infusion EU/1/98/067/001 |
Rituximab |
Roche Registration GmbH |
— |
| MabThera 1400 mg concentrate for solution for infusion EU/1/98/067/003 |
Rituximab |
Roche Registration GmbH |
— |
| MabThera 1600 mg concentrate for solution for infusion EU/1/98/067/004 |
Rituximab |
Roche Registration GmbH |
— |
| MabThera 500 mg concentrate for solution for infusion EU/1/98/067/002 |
Rituximab |
Roche Registration GmbH |
— |
| Madopar 100 mg/25 mg dispersible tablets PA2307/004/003 |
Levodopa, Benserazide |
Roche Products (Ireland) Limited |
Marketed |
| Madopar 200 mg/50 mg hard capsules PA2307/004/001 |
Levodopa, Benserazide |
Roche Products (Ireland) Limited |
Marketed |
| Madopar 50 mg/12.5 mg dispersible tablets PA2307/004/002 |
Levodopa, Benserazide |
Roche Products (Ireland) Limited |
Marketed |
| Mircera 100 micrograms/0.3 ml solution for injection in pre-filled syringe EU/1/07/400/10 |
Methoxy peg-epoetin beta |
Roche Registration GmbH |
— |
| Mircera 120 micrograms/0.3 ml solution for injection in pre-filled syringe EU/1/07/400/20 |
Methoxy peg-epoetin beta |
Roche Registration GmbH |
— |
| Mircera 150 micrograms/0.3 ml solution for injection in pre-filled syringe EU/1/07/400/11 |
Methoxy peg-epoetin beta |
Roche Registration GmbH |
— |
| Mircera 200 micrograms/0.3 ml solution for injection in pre-filled syringe EU/1/07/400/12 |
Methoxy peg-epoetin beta |
Roche Registration GmbH |
— |
| Mircera 250 micrograms/0.3 ml solution for injection in pre-filled syringe EU/1/07/400/13 |
Methoxy peg-epoetin beta |
Roche Registration GmbH |
— |
| Mircera 30 micrograms/0.3 ml solution for injection in pre-filled syringe EU/1/07/400/17 |
Methoxy peg-epoetin beta |
Roche Registration GmbH |
— |
| Mircera 360 micrograms/0.6 ml solution for injection in pre-filled syringe EU/1/07/400/21 |
Methoxy peg-epoetin beta |
Roche Registration GmbH |
— |
| Mircera 50 micrograms/0.3 ml solution for injection in pre-filled syringe EU/1/07/400/008 |
Methoxy peg-epoetin beta |
Roche Registration GmbH |
— |
| Mircera 75 micrograms/0.3 ml solution for injection in pre-filled syringe EU/1/07/400/009 |
Methoxy peg-epoetin beta |
Roche Registration GmbH |
— |
| NeoRecormon EU/1/97/031/019 |
Epoetin beta |
Roche Registration GmbH |
— |
| NEORECORMON EU/1/97/31/45-46 |
Epoetin beta |
Roche Registration Limited |
— |
| NeoRecormon 10000 IU Solution for injection EU/1/97/031/035 |
Epoetin beta |
Roche Registration GmbH |
— |